ABSTRACT. Sera from obligate heterozygotes for deficiency of the C8P subunit of the eighth component of human complement (C8) were analyzed for the molecular composition of C8. The C8a-y and C8/3 subunits were separated by SDS-PAGE, visualized by immunoblotting, and the resulting bands were quantitated by laser densitometry. The laser densitometric absorption data were set to 100 arbitrary units (AU) for both subunits of pooled normal human sera. The AU values of individual normal sera ranged from 45 to 150 AU for C8a-7 (median 99 AU) and from 45 to 140 AU for C8P (median 101), whereas the C8a-y/C8/3-ratio varied from 0.7 to 1.4. Sera from C8P-deficient heterozygotes differed, as expected, from the normal sera for the markedly reduced levels of C8B (20 to 90 AU, median 55 AU) and for the higher C8a-ylC8B-ratio (1.3 to 3.5). High voltage agarose gel electrophoresis was used to separate free and C8B-bound C8a-y. The migration of free and C8p-bound C8a-y subunit was checked by hemolytic overlay gels and by second dimension SDS-PAGE and immunoblotting. Immunochemical evaluation of C8a-y using this system revealed about 5-14% free C8a-y in sera with normal C8 and higher levels, from 33-71 %, in the C8BD heterozygous sera. Functional analysis confirmed the substantial increase of free C8a-y in the heterozygous group. We conclude that the C8 in C8PD heterozygous sera is characterized by increased amounts of free C8a-y due to reduced concentrations of the C8P subunit. This finding may help to identify individuals heterozygous for C8@ deficiency. (Pediatr Res 27: 234-238, 1990) Abbreviations C8, eighth component of human complement C8BD, C8P deficient C8 a-yD, C8a-y deficient GVBS, glucose veronal buffered saline HVAE, high voltage agarose gel electrophoresis
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The congenital deficiency of the @-subunit of the eighth component of the complement system (C8) has been reported in more than 40 individuals (1). The diagnosis of the C8@ defect can easily be made for the homozygotes whose sera lack C8 lytic activity. These sera contain an immunochemically detectable C8a-y subunit cross-reacting with the C8 of NHS with pattern of partial Ag identity (2, 3). The C8a-y present in C8@-deficient sera, however, is not dysfunctional because it is still capable of reacting with the @-subunit to form a hemolytically active C8 molecule (4, 5). Unlike the homozygotes, the individuals heterozygous for C8P deficiency are somewhat more dificult to recognize due to the broad range of antigenic and hemolytic values of C8 in control populations. Search for null genes in family studies may be of some help when positive, but this is not always the case (6) .
A more practical approach to screen for heterozygotes for C8@ deficiency is provided by the findings of Brandslund et al. (7) . The authors showed two anti-C8 reacting components with aand @-mobility in normal human plasma, whereas the p-component was absent in the plasma obtained from one C8-deficient patient later recognized to have a C8@ defect (F. Tedesco and I. Brandslund, unpublished observation), and was reduced to half normal levels in the plasma of both parents and two siblings of the propositus. This study, however, did not clarify the molecular nature of the two components with respect to the subunit composition of C8 and it was not extended to include other families with a similar defect.
The purpose of our investigation is to show that the heterozygotes for C8P-deficiency can easily be recognized by measuring the a-y-and the @-subunit of C8. In addition, evidence will be provided, indicating that these subjects present increased levels of free C8a-y in their sera as compared to the control population.
MATERIALS AND METHODS
Sera. Blood samples were collected from 32 normal individuals, five homozygous C8PD patients, and the 10 parents of these patients, allowed to clot at room temperature for 30 min, and stored in small aliquots at -80°C. Control sera were obtained from healthy laboratory personnel and blood donors, and were used either individually (NHS) or as a pool of equal volumes of all sera (PNHS). Details of the C8PD patients have been given in previous reports (3, 5, 8, 9) . A serum sample of a C8a-yD patient was a generous gift from Dr. B. Petersen (Lilly Laboratory for Clinical Research, Indianapolis, IN). Sera from abroad were shipped on dry ice. Complement activation in the sera was checked by determining the C3dg concentration as described previously (1 0).
Antisera. Four polyclonal antisera against the whole C8 molecule were obtained from the following sources: A, goat antihuman C8 (Cappel, Cochranville, PA); B, goat anti-human C8 (Atlantic antibodies, Scarborough, ME); C, rabbit anti-human C8 (Calbiochem, La Jolla, CA); and D, rabbit anti-human C8 (our own preparation) (4). The antibodies A and C were diluted 1 in 2000, the antibodies B and D in 1 in 1000. Sources of alkaline phosphatase-labeled antibodies were goat anti-rabbit IgG (Jackson-Dianova, Hamburg, FRG) diluted 1 in 4000, and rabbit anti-goat IgG (Sigma, Munich, FRG) diluted 1 in 1200.
SDS-PAGE and immunoblot analysis of C8. The previously described procedure for the analysis of the C8 subunits (5) was followed with minor modifications. These include the electroblotting at 1.2 mA/cm2 gel surface for 70 min using a semi-dry blotting apparatus (I 1) and a continuous buffer system (12) .
Laser densitometric evaluation of C8a-y and C8P subunits. The immunostained C8a-y and C8P bands were quantitated by laser densitometry using a neon-helium laser at 633 nm wavelength (UltroScan 2202, Pharmacia, Bromma, Sweden). Inasmuch as the C8a-y subunit is polymorphic and gives two or three bands in different sera ( 9 , the absorption values of the individual bands were added together to obtain the total amount of the C8a-y subunit. The C8a-y and C8P values were expressed as AU, which were calculated considering equal to 100 AU for both the C8a-y and the C8P subunit of PNHS diluted 1 in 60. Consequently, all the samples to be tested were diluted 1 in 60, and their absorption values were referred to a standard curve constructed with dilutions of PNHS ranging between 1 in 15 to 1 in 480 (in 150 mM sodium chloride) assayed in parallel. Although the shape of the standard curve was sigmoidal for both C8a-y and C8P, the absorption values were linear over a dilution range of PNHS between 1 in 30 and 1 in 240. The calculated C8a-ylC8P-ratio was stable in the range from 25 AU to 200 AU for PNHS. The C8a-ylC8P ratio was calculated as follows:
C8a-y(AU) C8a-ylC8p ratio = C8P (AU) HVAE. A 0.5-mm agarose gel was prepared by mixing equal volumes of agarose type A (Calbiochem) with an electroendosmosis of -0.13 M, in distilled water and Tris-glycine buffer, pH 9.6, to a final concentration of 1% agarose, 180 mM Tris, 90 mM glycine, and a conductivity of 1000 ps/cm at room temperature. The mixture was prewarmed to 6OoC, poured between two glass plates (12.5 x 16 cm), one of which had been covered with a Mylar cellophane sheet (LKB, Bromma, Sweden) and left to solidify at 4°C for about 2 h. Electrophoresis was performed at 10°C using the LKB apparatus (Multiphore 2 1 17) with a 30-min prerun at 15 V/cm. The 1 -to 2-pL samples were then applied to 0.6 x 7 mm slots in the agarose gel and, after a 30-min run at 6 V/cm, the voltage was adjusted to 40 V/cm. The electrophoresis was stopped when Hb, used as a marker, had migrated 8 cm from the application side, which was reached after a 60 to 70 min run. The agarose gel was then processed either for a second dimension SDS-PAGE and subsequent blotting onto nitrocellulose or for the hemolytic overlay to reveal the C8 hemolytic bands.
Second dimension SDS-PAGE. Conditions for the second dimension SDS-PAGE were similar to those reported above. Agarose gel strips from HVAE cut along the direction of the electrophoretic run were rinsed in the sample buffer containing 1.5% SDS and 62.5 mM Tris and deposited on top of the polyacrylamide gel. PNHS (0.5 pL) and a marker solution (Bio-Rad, Richmond, CA) were run in parallel. The C8 bands were electroblotted onto nitrocellulose and subsequently revealed using the anti-C8 antiserum from N. L. Cappel Laboratories, Cochranville, PA. Quantitation was carried out by measuring the area of the stained spots. A linear relationship between size of the spots and serum dilution was found from 3 to 70% for free C8a-y.
Detection of functionally active C8a-y and C8P by hemolytic overlay gel. The procedure for the preparation of EACl-7 using a C8PD serum has been previously reported (3). It is now well established that the C8PD sera contain the C8a-y subunit that is unable to bind to EAC1-7 (4). A 10% EACI-7 suspension in GVBS was incubated with 20% (vol/vol) C8a-yD serum or 20% (vol/vol) C8PD serum (for 10 min at 37°C) to prepare erythrocyte intermediates suitable for assaying functional C8P and C8a-?, respectively. Equal amounts of the erythrocyte intermediates in twice concentrated GVBS and agarose (Indubiose A 37, Rkactifs IBF, Villeneuve, France) suspended in distilled water were mixed at 50°C to obtain a final suspension containing 1 % erythrocytes and 1 % agarose in GVBS. A volume of this mixture sufficient to prepare a 1.3-mm thick overlay was poured onto a prewarmed agarose gel, which had been quickly rinsed with GVBS to remove the electrophoretic buffer after completion of HVAE. The gels were kept in a humid chamber for 3-4 h at 37°C until the hemolysis was visible. Further lysis was prevented by soaking the gels in 2% glutaraldehyde in 150 mM sodium chloride at 4°C for 30 min.
Statistical analysis. The coefficient of variance and the Pearson's correlation coefficient were calculated using standard programs (Hewlett-Packard Co., Palo Alto, CA).
RESULTS

Standardization of SDS-PAGE and blotting procedure.
Initial experiments were performed to find the optimal conditions for a correct quantitation of C8a-y and C8P subunits in human sera. Various attempts were made to select the transfer time that allowed quantitative transfer of C8 subunits from the polyacrylamide gel to the nitrocellulose sheet. The optimal transfer time was found to be 70 min. To prevent differences in the reaction of the various polyclonal antisera for each of the two subunits from leading to erroneous results, four anti-C8 antisera were examined and the Cappel antiserum was chosen to give the best estimate of the C8a-y and C8P values. The interassay coefficient variance was 13.6%. Representative patterns and laser densitometric profiles of the C8 subunits in PNHS and in two sera obtained from a homozygote and a heterozygote for C8P deficiency are presented in Figure 1 . As expected, C8P was undetectable in the homozygote and substantially reduced in the heterozygote when compared to the C8P level in PNHS. Analysis of four additional sera from patients homozygous for C8P deficiency confirmed the defect of C8P and the presence of C8a-y, though the latter showed some quantitative variations among patients.
Quantitation of C8a-y and C8P in C8PD heterozygotes. The SDS-PAGE and blotting procedure was used to examine the sera of the 10 parents of the C8PD patients and, for comparison, those of 32 control sera for their C8a-y and C8P levels with the intent to recognize the heterozygous state. The results shown in Figure 2 indicate that the two groups had similar values of C8a-y ranging between 45 and 150 AU, and differed markedly for the levels of C8P. The C8P values in the control group ranged from 45 and 140 AU, whereas eight of the heterozygotes, including the five mothers, had C8P levels less than 40 AU and the remaining two had C8P values in the lowest range of control values. The heterozygotes also differed from the controls in the C8a-ylC8P ratio, which did not exceed 1.38 in the control sera but rose to 1.7 and more in the majority of the heterozygotes. In the normal population, a strong correlation was found between the C8a-y and the C8P-values, which was not detectable in the Pearson's correlation). Inasmuch as separate experiments had shown that immunostaining of C8P tends to be weaker after in vitro complement activation by inulin, all sera were tested for the levels of C3dg, which did not differ between controls and heterozygotes and was not higher than 3% (data not shown).
Free C8a-y is increased in heterozygotes. The relatively high ratio of C8a--y to C8P in the heterozygous group may be explained by the presence of increased amounts of free C8a-y in the sera of these individuals. To test this hypothesis, HVAE of heterozygous and control sera was camed out and functional C8a-y was detected by the hemolytic overlay system using EAC 1-C8P plus C9 as described in Materials and Methods. Figure 3 demonstrates that two distinct areas of lysis were detected in NHS showing relative electrophoretic mobilities of 20-50 and 60-90% with respect to that of Hb. The cathodal lytic area was the only one observed when both NHS and C8a-yD serum were tested with the erythrocyte intermediate prepared with a C8PD serum (data not shown). Conversely, the C8PD serum exhibited only the anodal lytic area (Fig. 3, lane a) . From these results we concluded that the cathodal lytic area reveals the whole C8, whereas the anodal lytic area only shows free C8a-y. The control and the heterozygous sera showed different lytic patterns when examined with EACl-8P and C9. Thus, the cathodal area was more intense in the controls, whereas the anodal area was more prominent in the heterozygous group (Fig. 3) . To confirm that the two lytic areas of NHS seen after HVAE correspond to complete C8 and free C8a-y, two-dimensional electrophoresis was performed using HVAE followed by SDS- Fig. 3 . Functional analysis of C8a-y separated by HVAE revealed by hemolytic overlay gels (see Material and Methods) . Cathode is on the . -top, the position of the Hb at the end of the electrophoretic run is indicated by C. The figure shows the resulting lytic patterns (zones of hemolysis are white) for a C8PD homozygous serum (a), C8PD heterozygous sera (I, 2, 3, 7, 8, 9) and normal control sera (4, 5, 6, 10, 1 I, 12). Zone A represents the lytic area of C8a-7 bound to C8P (whole C8), whereas zone B corresponds to that of free C8a-y. The C8PD homozygous serum lacks the slowly migrating C8a-y (zone A), which is bound to the C8P subunit (see Fig. 4 ). C8PD heterozygotes and normal individuals show two zones of lysis ( A ) and (B). Note, that the lytic zone B is stronger in CRPD heterozygous than in the normal control sera.
PAGE under nonreducing conditions and subsequent blotting. As shown in Figure 4 , on SDS-PAGE the cathodal area of NHS resolved into two bands with molecular mass of 87 and 64 kD, which represent C8a-y and C8P, respectively, whereas the anodal area gave only the 87-kD band. A pattern similar to that of NHS was observed with the serum of a heterozygous individual, whereas the serum from a C8PD homozygous patient only showed the 87-kD band corresponding to the anodal area on HVAE.
To quantitate the relative amounts of free and C8p-bound C8a-y, sera from 10 heterozygous and nine control subjects were examined by two-dimensional electrophoresis and subsequent immunoblotting. The results presented in Table 1 indicate that free C8a-y represents about 5-14% of the total C8a-y and also that the amount of free C8a-y increases in the heterozygotes to reach values equal or higher than those of the C8P-bound form. DISCUSSION SDS-PAGE and immunoblotting procedure has been shown to be useful for measuring C8a-y and C8@ in human sera (5). We now show that it allows recognition of most of the heterozygotes for C8P deficiency. In the Norwegian population, 5-10% were considered to be heterozygous for C8P deficiency (13) .
The wide range of C8a-y and C8P values observed in the control group are in accordance with results obtained in normal human sera with the immunochemical and hemolytic evaluation of the whole C8 molecule (3). Variability in the transfer of the two subunits from the polyacrylamide gel to the nitrocellulose sheet is unlikely to account for these results because the coefficient of variance was lower than 15% on repeated examination of the same sera. Although normal values of C8a-y and C8P in sera vary over a wide range, our results show a highly significant correlation between the amounts of C8a-y and that of C8P. The possible existence of a common regulatory control for the synthesis of the two subunits is suggested, although not formally proven, by studies of C8 polymorphism showing close linkage of the two different loci encoding the a-y-and the @-subunit (14) . In addition, studies by Ng and Sodetz (15) , on the biosynthesis of C8 by rat hepatocytes, have clearly shown that C8a-y and C8@, although separately produced, have a preferential tendency to assemble intracellularly as whole C8 due to the high affinity of C8a-y and C8@. The suggestion has therefore been made that the synthesis of the two subunits is regulated to allow maximal formation of the assembled molecule (15, 17) . Whatever the mechanism responsible for the regulatory control of C8a-y and C8@ production, this is certainly not working in the heterozygotes and in the homozygotes for C8P deficiency. In these individuals, the serum concentration of C8a-y is independent from that of C8@. The low levels of C8P in the heterozygous group confirm and extend previous observations by Brandslund et al. (7) , who analyzed the sera of family members of a C8@D patient by crossimmunoelectrophoresis. The advantage of our experimental approach is that it allows the definition of the relative amounts of the two subunits of C8 without the requirement of subunitspecific antibodies.
The results of our studies also indicate that the reduced secretion of C8p in the heterozygotes is accompanied by a correspondent increase in free C8a-y. Evidence for the presence of free C8a-y in human sera has been obtained using subunit-specific MAb (16) and electrophoretic analysis or exchange chromatography of the sera (17) . A similar conclusion was drawn by Ng and Sodetz (15) in their study on C8 biosynthesis showing extracellular secretion of free C8a-y by rat hepatocytes. Our results are in agreement with those of Doglio et al. (18) who demonstrated small amounts of free C8a-y in sera with normal C8 and substantial levels of this subunit in the sera from C8PD heterozygotes. Free C8a-y retains its fully hemolytic activity and this is even increased in the C8PD heterozygotes compared to the activity of the C8p-bound C8a-y. The in vivo role of free Fig. 4 . Patterns of two-dimensional electrophoresis (first dimension HVAE, second dimension SDS-PAGE) of 1 p L NHS (A), 1 p L C8PD heterozygous sera (B), and 1 pL C8P-deficient serum (C). The mol wt markers (m. w.) are indicated on the left, the positions of the C8a-y and C8P subunit on the right. NHS, normal human serum, analyzed only by SDS-PAGE as control for the C8a-y and C8P position; T, position, where the sample was applied for one-dimensional electrophoresis; C, position, to which Hb was allowed to migrate in the first dimension; A, region of slowly migrating C8, which is composed of C8a-y and C8P; B, region of fast migrating C8, which shows a C8a-y band only.
